anti-OBT698R agonist monoclonal antibody (Oxford BioTherapeutics)

N/A

Report date: 2025/06/11 10:34:47

Base Information

Drug Nameanti-OBT698R agonist monoclonal antibody (Oxford BioTherapeutics)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionImmunostimulants
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOxford Biotherapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesOxford Biotherapeutics Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A